RT @drdavidliew: Is channelling bias a risk, because of treating clinicians 'protecting' pre-existing autoimmune dx pts:
Tweet Content
Is channelling bias a risk, because of treating clinicians 'protecting' pre-existing autoimmune dx pts: maybe?
Certainly in practice, these pts might get less combo immunoRx; this @mcgillu data would suggest so
Much more to understand across tumor streams
ABST0760 #ACR22 https://t.co/z1rhAJZ9gj
Show on Archive Page
On
Display in Search Results
On
PDQ
Off